Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Erythropoiesis and iron.

I Cavill1

  • 1Department of Haematology, University of Wales College of Medicine, Cardiff CF14 4XN, Wales, UK.

Best Practice & Research. Clinical Haematology
|October 29, 2002
PubMed
Summary
This summary is machine-generated.

Iron is vital for red blood cell production (erythropoiesis), requiring significant daily intake. Functional iron deficiency, often seen in anemia, necessitates intravenous iron therapy for effective treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The need for a Blood Transfusion Service.

Transfusion medicine (Oxford, England)·2005
Same author

Automated haemoglobinopathy screening.

Clinical and laboratory haematology·2004
Same author

Iron, anaemia, and inflammatory bowel diseases.

Gut·2004
Same author

Single value of serum transferrin receptor is not diagnostic for the absence of iron stores in anaemic patients with rheumatoid arthritis.

Clinical and laboratory haematology·2003
Same author

Benefits of recombinant human erythropoietin.

Lancet (London, England)·2002
Same author

Red cell lifespan estimation by (51)Cr labelling.

British journal of haematology·2002

Area of Science:

  • Hematology
  • Nutritional science
  • Internal medicine

Background:

  • Erythropoiesis, the process of red blood cell formation, has a high daily iron requirement (30-40 mg).
  • Iron supply for erythropoiesis is typically met by red blood cell destruction, but this is insufficient in anemia.
  • Reduced or inadequately supplied iron stores can impair erythropoiesis, especially during erythropoietin therapy.

Purpose of the Study:

  • To highlight the critical role of iron in erythropoiesis.
  • To define and explain "functional iron deficiency" as a cause of treatment failure in anemia.
  • To emphasize the necessity of intravenous iron therapy for functional iron deficiency.

Main Methods:

  • Review of the physiological requirements of iron in erythropoiesis.

Related Experiment Videos

  • Analysis of iron supply dynamics in normal and anemic states.
  • Evaluation of diagnostic markers for iron status and erythroid iron supply.

    • Main Results:

    • Functional iron deficiency is a common cause of unresponsiveness to erythropoietin therapy.
    • Intravenous iron administration is the effective treatment for functional iron deficiency.
    • Percentage of hypochromic red cells is a key indicator of effective erythroid iron supply, complementing hemoglobin and ferritin levels.

    Conclusions:

    • Adequate iron supply is essential for effective erythropoiesis, particularly under stimulated conditions.
    • Functional iron deficiency requires specific management with intravenous iron.
    • Monitoring hypochromic red cells provides crucial insight into erythroid iron utilization.